Merck Pharmaceutical Projects Over $1M In Lab Savings with Motion C5-Series Mobile Platform

Merck scientists concluded that Motion’s mobile technology provided a full range of new and improved capabilities, which maximized their ELN investment and improved the scientists’ productivity.

“The integration of the C5 with the electronic notebook was a successful proof-of-concept. Scientists had more time to focus on value added work in labs and data integrity and document sensitivity compliance increased. Records become 100% electronic – promoting full ELN adoption.”